Commercialization: Page 27
-
PharmaVoice Team/PharmaVoice
SHOWCASE: mHealth: The Power of mHealth in Transforming Health Delivery
Investment in mHealth is growing and in the first half of 2017 $3.5 billion was invested in 188 digital health companies. According to Juniper Research, the number of wearable devices will reach 130 million in 2018 at an estimated value of $19 billion. Its use has become widespread in medical set...
By PharmaVoice Team • May 1, 2018 -
PharmaVoice Team/PharmaVoice
Introducing BYOD 2.0: A More Inclusive Approach to Electronic Clinical Outcome Assessment
In its list of “Top 10 Strategic Trends for 2018," Gartner, Inc., notes that the digital and physical worlds are becoming more closely aligned. This phenomenon is certainly observable in clinical research, as technology is supporting more effective remote research through the use of electronic cl...
By Chris Watson • May 1, 2018 -
PharmaVoice Team/PharmaVoice
The Connection for Patients to mHealth and Modern Patient Empowerment
Our mobile-first, soon to be mobile-only world We live in a mobile-first world. The fact is nearly 7 in 10 Americans1 are using mobile devices every day and many of those are finding less relevance with “desktop" computing. There is something incredibly liberating in having a device with you all ...
By Chris Cullmann • May 1, 2018 -
PharmaVoice Team/PharmaVoice
Biotech Buzz
Venture capital funding trends indicate a healthy environment for biopharma companies. The recent five-year trend has been very good with more dollars being deployed into venture-backed companies, many of which are R&D focused; there is more money available to biopharma companies compared wit...
By Denise Myshko • May 1, 2018 -
PharmaVoice Team/PharmaVoice
New Players and Old Disrupting The Industry
Disruption has become the new normal for the healthcare and life-sciences industry. And while several companies — industry incumbents, such as payers and providers — have been pursuing strategies to transform the industry and create greater efficiencies, the dynamic changed with the entry of tech...
By Kim Ribbink • May 1, 2018 -
PharmaVoice Team/PharmaVoice
Speak Out
Synchronizing HCP and Consumer Messages: At The Point of Care and Beyond Mobile devices have transformed the way we experience the world – including how we wait for things to happen. Look around any doctor’s office waiting room, or the line at the pharmacy, or the treadmills at your local gym. Pe...
By Rick Morello • May 1, 2018 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Getting personal There’s a pretty good chance that everyone reading this special issue — Patients’ Voices — is either a patient, a caregiver to a patient, or knows someone who has been diagnosed with a chronic or acute condition. But just because we are all patients or know a patient doesn’t mean...
By Taren Grom • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Upfront
Amicus Therapeutics Launches Healing Beyond Disease Amicus Therapeutics has launched Healing Beyond Disease, a global, employee-driven initiative inspired by people living with rare diseases and their families. Healing Beyond Disease is designed to enhance and expand the company’s support for pat...
By PharmaVoice Team • April 1, 2018 -
PharmaVoice Team/PharmaVoice
HealthTech
Patient-Centered Apps Trend Watch: Pharma Increases Consumer-Facing Apps and Digital Tools Pfizer Launches Novel Programs To Put Important Support Services At The Fingertips Of Cancer Patients Pfizer has developed enhanced offerings to help patients manage their life with cancer. Pfizer Oncology ...
By PharmaVoice Team • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Last Word
Acquisition and Integration Jane Griffiths, Ph.D., Global Head of Actelion, discusses the process of integration post acquisition by Johnson & Johnson in November 2017. PV: Why did J&J acquire Actelion? Griffiths: J&J had spotted Actelion several years prior to the acquisition because...
By Jane Griffiths • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Patients' Voices
PharmaVOICE editors have been writing about patient-centricity and all this topic encompasses for what seems like a decade. Some say the term has lost meaning because of its ubiquituous use. We contend that patients are leading the way and influencing how businesses operate today. For sure, there...
By PharmaVoice Team • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Patient-Based Business Strategies
With patients taking center stage in discussions around new products, tools, and technologies, it’s not surprising to see so many companies moving the patient to the center of their operational business strategies, starting in the clinic all the way through to commercialization. Liz Lewis, chief ...
By Taren Grom • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Patients and Health Literacy
What people know about health and healthcare and what they do with that knowledge has a major impact on their health and well-being. When patients are given health information in a way they can understand, they tend to make better health decisions. Low health literacy, on the other hand, is a con...
By Denise Myshko • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Patient Journeys And Storytelling
Real life patient stories started seeping into the pharma lexicon well over a decade ago, on both a commercial and research level. The industry began turning to end users to discover how to create better drug delivery processes, clinical trial protocols, and marketing efforts, as well as to accur...
By Robin Robinson • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Technology and Patient-Centric Trials
The term patient-centric is about ensuring the needs and perspectives of the patients are taken into consideration while maintaining scientific rigor for a clinical trial. Pharmaceutical sponsors have begun engaging patients in the trial design, seeking input and acknowledging the importance of t...
By PharmaVoice Team • April 1, 2018 -
PharmaVoice Team/PharmaVoice
The Changing Role of Patient Advocacy
The role of patient advocacy is a broad one — from supporter, to sponsor, to campaigner, to spokesperson and beyond. Indeed, patient advocacy means different things to different stakeholders, says Keri McDonough, senior team leader, Biosector 2, a Syneos Health company. “When patient advocacy gro...
By Kim Ribbink • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Patient-Centered Apps
The pharmaceutical industry is up against several challenges when it comes to developing mobile apps for its consumers. According to Deloitte, issues of consumer trust, app design, and regulatory concerns can throw up roadblocks in the very crowded and competitive field of 300,000-plus healthcare...
By PharmaVoice Team • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Executive Perspective: The Lens of Health Psychology
As chronic illness continues to dominate the healthcare landscape, more and more people are being charged with taking active roles in managing their condition and treatment. Laura Moore, Ed.D., CHES, Lead Health Psychology Specialist at Atlantis Healthcare, believes the field of health psychology...
By Laura Moore • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Speak Out
Prepare the market to be disrupted. Better yet, disrupt the market to prepare. Most marketers dream of having a product that is so innovative that it creates a huge disruption when it enters the market. Combine that with an edgy creative campaign, compelling data, and a big marketing budget, and...
By Rob Peters • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Upfront
CSL Behring Trains Employees to Save Lives in Their Communities CSL Behring is taking its workplace wellness initiatives to a whole new level by providing the American Heart Association’s (AHA) hands-only cardiopulmonary resuscitation (CPR) training to employees. With the help of the AHA and the ...
By PharmaVoice Team • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Last Word
Partnering for Public Health Rajeev Venkayya, M.D., President of the Global Vaccines Business Unit at Takeda, discusses why the pharmaceutical industry has to be a partner in public-health issues. PV: Why is it important for pharmaceutical companies to play a part in public-health discussions, pa...
By Rajeev Venkayya • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Moving Beyond the "Beyond the Pill" Conversation
The pursuit of better outcomes from all sides of the healthcare equation is driving the creation of more and more digital treatments and supplemental services as drug companies strive to prove, and increase, the value of their drugs — to payers, physicians, and patients. The value-add of these di...
By Robin Robinson • March 1, 2018 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Brand Building: Building the Brand in a Competitive and Digital Market
Until recently, branding in the pharmaceutical industry has meant developing a product and getting a patent for that product to market it exclusively, preparing a launch campaign, and advertising the product to clinicians and patients. Today, however, pharma companies need to think differently an...
By PharmaVoice Team • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Maximize Brand Health
In today’s complex healthcare marketplace, brands continue to be a potent force. Brands, among other things, are vehicles for engagement, creating strong connections between businesses and the people they serve. When brands are vibrant and alive, businesses flourish. By maximizing brand health, m...
By Steve Hamburg • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Do Brands Have Value After Exclusivity?
When a successful product is about to lose its exclusivity, and is facing incursions by generics or biosimilars, a pharmaceutical manufacturer sometimes decides to walk away. Rather than stand and fight the intruders, resources are demobilized, sales forces are reassigned, and management turns it...
By Ivan Deza • March 1, 2018
Previous
